Pharmaceutical innovation and spending control: the difficult combination of proof of a historic breakthrough

Roundtable

Last December 9th the Roundtable on the theme "Pharmaceutical innovation and spending control: the difficult combination to test a historical turning point" took place with the participation of Stefano DA EMPOLI (I-Com), Davide INTEGLIA (I-Com), Claudio RUSSO (Unimol), Americo CICCHETTI (High School of Economics and Management of ALTEMS Health Systems and Catholic University of the Sacred Heart) , Luca PANI (AIFA), Walter RICCIARDI (Istituto Superiore di Sanità), Enrico BELVISO (Daiichi Sankyo Italia), Luigi BOANO (ASSOBIOTEC), Paolo CIONINI (LEO Pharma), Paola DE ANGELIS, Government Affairs Manager Novartis Farma, Antonio GAUDIOSO (Cittadinanzattiva), Roberto GIRARDELLO (AbbVie), Andrea MANTOVANI (Sanofi), Alberto MIGLIORE (San Pietro Fatebenefratelli Hospital), Francesca PATARNELLO (Amgen), Roberto PESCI (Bayer), Federico SERRA (Novo Nordisk) and Maurizio TROPEA (Bristol-Myers Squibb) .